EMA — authorised 19 November 2019
- Marketing authorisation holder: AERIE PHARMACEUTICALS IRELAND LTD
- Status: approved
🇪🇺 Rhopressa in European Union
EMA authorised Rhopressa on 19 November 2019
Marketing authorisation
Rhopressa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in European Union
Frequently asked questions
Is Rhopressa approved in European Union?
Yes. EMA authorised it on 19 November 2019.
Who is the marketing authorisation holder for Rhopressa in European Union?
AERIE PHARMACEUTICALS IRELAND LTD holds the EU marketing authorisation.